Stella Diagnostics Inc. (SLDX) Research

Stella Diagnostics Inc. is a molecular diagnostics firm primarily focused on advancing patient care strategies for individuals afflicted with severe esophageal disorders. The company's specialized clinical tests furnish physicians with crucial information regarding the molecular makeup of a patient's tissue, enabling them to ascertain if the disease is static, deteriorating, or undergoing malignant transformation. Additionally, Stella Diagnostics is engaged in the development of innovative diagnostic tools intended to provide healthcare professionals with enhanced molecular insights compared to conventional screening methods. The organization rebranded from its previous identity, JMP Properties, Inc., to Stella Diagnostics, Inc. in April 2021 and is based in Salt Lake City, Utah.

Market snapshot

Symbol
SLDX
Price
$0.01
Day change
0.00%
Market cap
$1.0M
P/E ratio
-0.77x
52-week range
0.01032-0.05195
Sector
Healthcare
Industry
Medical - Diagnostics & Research

Peer companies

  • Cann Group Limited (CNGGF)
  • Dogecoin Cash, Inc. (DOGP)
  • Interpace Biosciences, Inc. (IDXG)
  • IR-Med Inc. (IRME)
  • Rennova Health, Inc. (RNVA)
  • Revive Therapeutics Ltd. (RVVTF)
  • StateHouse Holdings Inc. (STHZF)
  • Therma Bright Inc. (TBRIF)

Open Stella Diagnostics Inc. (SLDX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.